DIBUCAINE OINTMENT

The Defense Logistics Agency awarded Contract SPE2DP26P1002 to MR UNLIMITED, LLC (CAGE 3W8H0) for the delivery of DIBUCAINE OINTMENT, with a total contract value of $14.00. The award was issued on July 14, 2026, following a solicitation issued on July 9, 2026, and the delivery is required within 15 days after the order date, targeting delivery by approximately July 24, 2026. The product, identified by NSN 6505-00-299-9535 and part number 00536-1211-95, is subject to strict medical packaging, preservation, and labeling standards, including compliance with Medical Marking Standard No. 1, MIL-STD-2073-1E, and applicable FDA regulations. Temperature controls for perishable medical items mandate refrigeration between 2°C–8°C or freezing between -25°C to -10°C, with specific DLA forms required inside packaging. All shipments must be marked with the Transportation Control Number, purchase order number, and ship-to address, and barcoding is implied through TCN and PO inclusion. The contract is governed by a comprehensive set of Federal Acquisition Regulation clauses, including 52.222-50 (Combating Trafficking in Persons) with Alternate I, 52.222-55 (Minimum Wages under EO 14026), 52.222-62 (Paid Sick Leave under EO 13706), and 52.219-8 (Small Business Subcontracting Requirements), all of which flow down to any subcontractors. Cybersecurity and supply chain compliance are enforced through clauses such as 252.204-7012 (Safeguarding Covered Defense Information), 252.204-7018 (Prohibition on Covered Telecommunications Equipment), and 52.240-1 (Unmanned Aircraft Systems Restrictions). The contractor must adhere to Buy American Act provisions under Alternate II of 252.225-7001 and comply with antiterrorism, privacy, and whistleblower requirements. Invoicing is exclusively through the Wide Area WorkFlow